Clinical Trials Update: Dec. 13, 2006
Eye Disorders/Infections Diabetes - Type 2 Rheumatoid Arthritis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This clinical research study will evaluate the safety and effectiveness of an investigational drug eye drop in people with pink eye. Pink eye symptoms may include eye redness, crusty and sticky eyes, yellow or green discharge, watery, irritated eyes, or eye swelling. This study involves three visits over approximately eight days, and patients will receive compensation for participation.
The research site is in Paramount, Calif.
Diabetes - Type 2
This is a research study of an investigational drug for type 2 diabetes. The study will last about 14 weeks and will require about four visits. Volunteers 18-80 who have type 2 diabetes currently treated with only metformin (Glucophage) and are otherwise generally healthy may qualify.
The research site is in Longmont, Col.
This study will evaluate the effectiveness of an investigational medication in controlling the signs and symptoms of rheumatoid arthritis when taken in addition to methotrexate. Candidates at least 18 who have active rheumatoid arthritis, are taking 10 mg to 25 mg of methotrexate per week, and have at least six tender joints and at least six swollen joints may qualify.
The research sites are located across the United States.
Copyright 2006 Thomson CenterWatch. All rights reserved.